15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 5 firms covering Acuren Corporation, 2 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a hold consensus. Targets span $9.00 to $16.00, a moderate spread. The average target of $12.20 sits 69% above the current $7.24. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.17 next quarter toward $0.50 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 ratings
Hold
Strong Buy00%
Buy240%
Hold240%
Sell120%
Strong Sell00%
Based on 5 analysts giving stock ratings to Acuren Corporation.
As of Jul, 2 of 5 firms rate TIC a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
TIC EPS & revenue forecast
EPS · NEXT QUARTER
$0.17
Range $0.14 – $0.20 · 3 analysts · -19289% YoY
Next period, 3 analysts expect Acuren Corporation to earn $0.17 a share (range $0.14 – $0.20), versus $-0.00 a year earlier. Full-year consensus is $0.29, growing to $0.50 the year after.
REVENUE · NEXT QUARTER
$593.0M
Range $584.1M – $598.0M · 3 analysts · +25% YoY
Revenue is expected to reach $593.0M (range $584.1M – $598.0M), +25.1% year-over-year. Full-year consensus is $2.2B, rising to $2.3B next year.
Top analysts covering Acuren Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on TIC.
#1
Jeff Martin
Roth MKM · Rank #206
Buy
$10.00+38.2% to target
Overall win rate
38%
+ Follow
#2
JC
Joshua Chan
UBS
Hold
$11.00+52.0% to target
Coverage
—
+ Follow
#3
TS
Tomohiko Sano
JP Morgan
Sell
$9.00+24.4% to target
Coverage
—
+ Follow
#4
Stephanie Moore
Jefferies
Buy
$16.00+121.1% to target
Coverage
—
+ Follow
#5
Alex Rygiel
Texas Capital Securities
Buy
$17.00+135.0% to target
Coverage
—
+ Follow
TIC stock forecast FAQ
What is TIC's average 12-month price target?+
The 5 analysts with a live target average $12.20 for Acuren Corporation over the next 12 months, ranging from a $16.00 high to a $9.00 low.
Is TIC stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 5 analyst ratings, 2 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for TIC?+
The Street-high target is $16.00 (Jefferies), and the Street-low is $9.00 (JP Morgan). The average of all 5 active targets is $12.20.
How many Wall Street analysts cover TIC?+
5 analysts have an active rating on Acuren Corporation, and 5 firms carry a live 12-month price target.
Who is the most accurate analyst covering TIC?+
Among analysts who currently cover TIC, Jeff Martin of Roth MKM has the strongest overall Quantellect track record (Rank #206). Their current call is Buy with a $10.00 target.
What is Acuren Corporation's projected EPS for next quarter?+
The consensus estimate is $0.17 per share (range $0.14 – $0.20) across 3 analysts. Full-year EPS is projected at $0.29, rising to $0.50 the following year.
How much revenue is Acuren Corporation expected to report next quarter?+
Consensus revenue is $593.0M (range $584.1M – $598.0M). Full-year revenue is projected at $2.2B, growing to $2.3B next year.
Have analysts been upgrading or downgrading TIC lately?+
As of Jul, 2 of 5 firms rate TIC a Buy (2 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their TIC calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
